.png?width=1920&height=1080&name=MicrosoftTeams-image%20(12).png)
Devyser Diagnostics AB publishes quarterly report for July to September 2023
“Devyser is reporting record sales growth (+50% organic growth) for the third quarter, a further...
News | September 06, 2023
Devyser and Thermo Fisher Scientific expand the collaboration for post-transplant NGS products by adding BrazilNews | July 17, 2023
Devyser’s NGS products for monitoring of kidney and stem cell transplant patients receive IVDR approvalsNews | June 29, 2023
Devyser launches two new genetic testing solutions for hereditary cancer
Devyser brands US laboratory and expands Thermo Fisher Scientific collaboration: CEO comment
Dear Devyser network, partners, and valued customers,
Devyser and Thermo Fisher Scientific collaborate to promote laboratory services to advance pharmaceutical research
Devyser and Thermo Fisher Scientific have entered into a collaboration agreement to promote...
Devyser and Thermo Fisher Scientific expand the collaboration for post-transplant NGS products by adding Brazil
Devyser and Thermo Fisher Scientific have agreed to expand commercial collaboration by including...